AMGN

Amgen Inc

• Simply Wall St·9h ago

  Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback

• Barron‘s·14h ago

  This Startup's Psoriasis Drug Studies Have Lifted Its Stock

• TipRanks·19h ago

  Amgen’s FORWARD II Gout Study: What a Less Frequent Krystexxa Schedule Could Mean for Investors

• Dow Jones·21h ago

  Amgen Is Maintained at Equal-Weight by Morgan Stanley

• NASDAQ·21h ago

  Weekly Buzz: MGNX Resumes LINNET; GSK Wins China Nod; FDA Okays Waters; NBIX Snaps Up SLNO

• Seeking Alpha·22h ago

  BeOne wins China approval for Amgen’s lung cancer drug Imdelltra

• TipRanks·22h ago

  Amgen price target raised to $326 from $309 at Morgan Stanley

• Simply Wall St·1d ago

  What Amgen (AMGN)'s TEPEZZA On‑Body Injector Phase 3 Results Mean For Shareholders

• Barron‘s·1d ago

  Eli Lilly's Foundayo Weight-Loss Pill Hits the Shelves. It's a Turning Point for the Stock.

• MarketWatch·1d ago

  Dow's 312-point rally highlighted by gains in shares of Amazon.com Inc., Caterpillar

• MarketWatch·1d ago

  Amazon.com Inc., Caterpillar share gains contribute to Dow's 125-point climb

• NASDAQ·1d ago

  Noteworthy ETF Outflows: TQQQ, LIN, TMUS, AMGN

• Dow Jones·1d ago

  Amgen Is Maintained at Neutral by Guggenheim

• Seeking Alpha·1d ago

  Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs